ProImmune Ltd, a global leader in life science reagents and services, announced the launch of its new ProVE SL self-loading MHC Class I monomers. The novel reagents for antigen-specific CD8+ T cell ...

Ascletis Pharma Inc announced that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical development candidate. Ascletis ...

Positive results from the global PREVAIL phase III trial showed that gefurulimab met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement from baseline ...

PharmaDrug Inc, a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines, announced that it has executed a definitive securities exchange ...

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the ...

Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, announced that it has submitted an unsolicited proposal to acquire Metsera, Inc. The acquisition of ...

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of its new Neurotoxicity Testing Services; expanding its established neuroscience discovery ...

The menace of counterfeit medicines has been a major issue the world has been facing for a long time now, and the Indian market was no exception. The front pages of the Indian newspapers have very ...

SpectronRx commences mass production of high-purity Actinium-225, to strengthen global supply for cancer therapies: Indiana Saturday, November 1, 2025, 15:00 Hrs [IST] SpectronRx, ...

The Bangalore District Druggists and Chemists Association (BDCDA) is proactively encouraging and assisting the retailers to ...

Breast cancer detection technologies have evolved from conventional histopathology to advanced molecular methods to offer diagnostic insights, informs Ajay Kandhari, managing director, DSS Imagetech ...

There is a need to redefine Glucagon-Like Peptide-1 (GLP-1) therapy to adopt metabolism first path towards diabetes care, says Hummsa Biotech founder Harshad Lalwani. “Biotechnology company, Hummsa ...